bromodeoxyuridine has been researched along with Glioblastoma with Sarcomatous Component in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, SL; Freytag, SO; Kim, JH; Kim, OB; Kim, SH; Kolozsvary, A | 1 |
| Freytag, SO; Kim, JH; Kim, SH; Rogulski, KR | 1 |
2 other study(ies) available for bromodeoxyuridine and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
Topics: Acyclovir; Animals; Antiviral Agents; Brain Neoplasms; Bromodeoxyuridine; Gliosarcoma; Male; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344; Simplexvirus; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 1995 |
Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
Topics: Blotting, Western; Bromodeoxyuridine; Cytosine; Cytosine Deaminase; Deoxyuridine; Enzyme Inhibitors; Escherichia coli; Flucytosine; Ganciclovir; Gene Expression Regulation, Viral; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Gliosarcoma; Humans; Nucleoside Deaminases; Prodrugs; Radiation Tolerance; Recombinant Fusion Proteins; Simplexvirus; Thymidine Kinase; Tumor Cells, Cultured | 1997 |